An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Vaccines, Blood & Biologics

ADZYNMA

STN: 125795
Proper Name: ADAMTS13, recombinant-krhn
Tradename: ADZYNMA
Manufacturer: Takeda Pharmaceuticals U.S.A., Inc.
Indication:

Prophylactic or on-demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP)

Product Information

Package Insert and Patient Information - ADZYNMA
Instructions for Use - ADZYNMA
Demographic Subgroup Information – ADAMTS13, recombinant-krhn [ADZYNMA]
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Top